Loading clinical trials...
Loading clinical trials...
The participants of this study will be of any age who are exposed to at least 1 dose of odevixibat at any time during pregnancy (from 1 day prior to conception to pregnancy outcome) and/or at any time...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ipsen
NCT06965530 · Pregnancy Related, Prematurity, and more
NCT06591247 · Labor, Induced, Cervical Ripening, and more
NCT06284278 · Postpartum, Pregnancy Related, and more
NCT07517549 · Sexuality, Depression, and more
NCT05942313 · Opioid Use Disorder, Pregnancy Related
Virtual Research Coordination Center Odevixibat (BYLVAY) Pregnancy Surveillance Program
Wilmington, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions